Facebook
Twitter
LinkedIn
ForwardStigma: Its Impact and What You Can Do
Program Release: March 5, 2024
Expiration Date: March 5, 2026
Estimated time to complete: 30 Minutes
There are no prerequisites for participation.
Funding provided by the Centers for Disease Control and Prevention (CDC) Overdose Data to Action in States Grant
This lecture provides medical professionals with best practices for working with patients with substance use disorders and/or those experiencing overdose based on the updated CDC Clinical Practice Guideline for Prescribing Opioids for Pain. Key topics include understanding the definition, manifestations and impact of stigma, the human side of overdose prevention and public health, why choosing the “right” words matters, and strategies to address stigma in and out of the work environment.
GUEST SPEAKERS
Warren Alpert Medical School of Brown University
Medical Director
Co-Director
TARGET AUDIENCE
This activity is designed for physicians, nurse practitioners, physician assistants, and residents and fellows in Rhode Island specializing in primary care, family medicine, general medicine, pediatrics and emergency medicine.
LEARNING OBJECTIVES
After participating in this educational initiative, the learner should be better able to:
- Recall the definition, manifestations, and impact of stigma.
- Understand the human side of overdose prevention and public health.
- Recognize why choosing the “right” words matters.
- Implement strategies to address stigma in and out of the work environment.
METHOD OF PARTICIPATION AND HOW TO RECEIVE CME CREDIT
There are no fees for participating in and receiving credit for this activity.
- Review the activity objectives, faculty information, and CME information prior to participating in the activity.
- Complete the pre-test
- View the CME presentation
- Complete the post-test
- Complete the CME activity evaluation in order to receive a credit certificate.
- Credit claiming is available at the end of each module.
FACULTY DISCLOSURE
In accordance with the disclosure policy of the Brown University CME Office as well as standards set forth by the Accreditation Council for Continuing Medical Education (ACCME), speakers have been asked to disclose any relevant financial relationship with the manufacturers of any commercial products and/or provider of commercial services discussed in any educational presentation and with any commercial supporters or exhibitors of this activity.
The intent of this policy is not to prevent a speaker with a potential conflict of interest from making a presentation but to identify openly so that the listener may form his/her own opinion. Any potential conflicts of interest have been resolved prior to this presentation.
This activity may include discussion of off-label or investigative drug uses. Speakers are aware that it is their responsibility to disclose to the audience this information. Individual faculty disclosure information may be found in the conference handouts.
Faculty Disclosure/Conflict of Interest
All speakers and planning committee members have disclosed that they have no relevant financial relationships.
DISCLAIMER AND PRIVACY POLICY
Privacy Policy: The Office of Continuing Medical Education (CME) and its educational partners protect the privacy of personal and other information regarding participants and educational collaborators. The CME Office maintains its internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME internet-based program. CME collects only the information necessary to provide you with the services that you request.
Disclaimer: This educational program is designed to present scientific information and opinion to health professionals, stimulate thought, and further investigation.
Warren Alpert Medical School of Brown University
Medical Director
Co-Director
Assistant Director, CME Accreditation and Special Projects
Office of Continuing Medical Education
Warren Alpert Medical School of Brown University
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Warren Alpert Medical School of Brown University and the Rhode Island Department of Health. The Warren Alpert Medical School of Brown University is accredited by the ACCME to provide continuing medical education for physicians.
Physicians: The Warren Alpert Medical School designates this live activity for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- Rhode Island Specific: This course qualifies for 0.5 hours of risk management credit.
Drug Enforcement Administration (DEA) Medication Access and Training Expansion (MATE) Act:
- This course can be counted toward the DEA licensure training requirement as noted in their 3/27/2023 communication. Course content aligns with SAMHSA’s content recommendations required by the 2022 Medication Access and Training Expansion (MATE) Act. A total of 8 hours is required. For further information and guidance regarding training requirements visit https://www.samhsa.gov/medications-substance-use-disorders/training-requirements-mate-act-resources
Available Credit
- 0.50 AMA PRA Category 1 Credit™The Warren Alpert Medical School of Brown University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
- 0.50 AttendanceParticipants will receive a Certificate of Attendance stating this program is designated for AMA PRA Category 1 Credit™. This credit is accepted by the AAPA and AANP.